Immune to Cancer: The CRI Blog
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.
-
ASCO 2015: Report from Day 2
The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.
-
ASCO 2015: Report from Day 1
A day for travel and educational sessions at the American Society of Clinical Oncology (ASCO).
-
ASCO 2015: 3 Tips for Patients
Tips for patients looking to follow the breaking cancer treatment news from ASCO 2015
-
ASCO 2015: What to Watch in Immunotherapy
Curious about what immunotherapy breakthroughs are coming at ASCO? Here’s a preview.
-
Going “Through the Kitchen” For a Good Cause
CRI's 33rd annual party at the Four Seasons restaurant raises record $1.42 million for cancer immunology research.
-
Twitter Chat: Melanoma and Immunotherapy
Join the #ImmunoChat conversation on May 19 at 4:00 p.m. ET.
-
CRI’s Insights for ASCO 2015
Our expert panel in cancer immunotherapy weighs in on what to look for at this year's meeting.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.